Advanced search
Publication Cover
Expert Opinion on Drug Discovery Volume 15, 2020 - Issue 11
Submit an article Journal homepage
412
Views
13
CrossRef citations to date
0
Altmetric
Perspective

Should drug discovery scientists still embrace the amyloid hypothesis for Alzheimer’s disease or should they be looking elsewhere?

Bruno Pietro Imbimboa Research & Development Department, Chiesi Farmaceutici SpA, Parma, ItalyCorrespondence[email protected]
View further author information
,
Stefania Ippatib Experimental Imaging Center, San Raffaele Scientific Institute, Milano, ItalyView further author information
&
Mark Watlingc CNS & Pain Department, Transcrip Partners LLP Reading, Berkshire, United Kingdom of Great Britain and Northern IrelandView further author information
Pages 1241-1251 | Received 02 Apr 2020, Accepted 06 Jul 2020, Published online: 20 Jul 2020

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Miguel Vaz, Vítor Silva, Cristina Monteiro & Samuel Silvestre. (2022) Role of Aducanumab in the Treatment of Alzheimer’s Disease: Challenges and Opportunities. Clinical Interventions in Aging 17, pages 797-810.
Read now

Articles from other publishers (12)

Daniel Felsky, Alyssa Cannitelli & Jon Pipitone. (2023) Whole Person Modeling: a transdisciplinary approach to mental health research. Discover Mental Health 3:1.
Crossref
Allison B. Reiss, Dalia Muhieddine, Berlin Jacob, Michael Mesbah, Aaron Pinkhasov, Irving H. Gomolin, Mark M. Stecker, Thomas Wisniewski & Joshua De Leon. (2023) Alzheimer’s Disease Treatment: The Search for a Breakthrough. Medicina 59:6, pages 1084.
Crossref
Barbora Svobodova, Lenka Pulkrabkova, Dawid Panek, Anna Misiachna, Marharyta Kolcheva, Rudolf Andrys, Jiri Handl, Jan Capek, Pavlina Nyvltova, Tomas Rousar, Lukas Prchal, Vendula Hepnarova, Martina Hrabinova, Lubica Muckova, Daniela Tosnerova, Galina Karabanovich, Vladimir Finger, Ondrej Soukup, Martin Horak & Jan Korabecny. (2023) Structure-Guided Design of N-Methylpropargylamino-Quinazoline Derivatives as Multipotent Agents for the Treatment of Alzheimer’s Disease. International Journal of Molecular Sciences 24:11, pages 9124.
Crossref
Shivani A. Muthu, Rahul Sharma, Afnaan Qureshi, Suhel Parvez & Basir Ahmad. (2023) Mechanistic insights into monomer level prevention of amyloid aggregation of lysozyme by glycyrrhizic acid. International Journal of Biological Macromolecules 227, pages 884-895.
Crossref
Yuxuan Dai, Chenyi Lei, Zhenhao Zhang, Yan Qi, Kejing Lao & Xingchun Gou. (2022) Amyloid-beta Targeted Therapeutic Approaches for Alzheimer’s Disease: Long Road Ahead. Current Drug Targets 23:11, pages 1040-1056.
Crossref
Bruno P. Imbimbo, Stefania Ippati, Mark Watling & Claudia Balducci. (2021) A critical appraisal of tau‐targeting therapies for primary and secondary tauopathies. Alzheimer's & Dementia 18:5, pages 1008-1037.
Crossref
Gabriel A. de Erausquin, Heather Snyder, Traolach S. Brugha, Sudha Seshadri, Maria Carrillo, Rajesh Sagar, Yueqin Huang, Charles Newton, Carmela Tartaglia, Charlotte Teunissen, Krister Håkanson, Rufus Akinyemi, Kameshwar Prasad, Giovanni D'Avossa, Gabriela Gonzalez‐Aleman, Akram Hosseini, George D. Vavougios, Perminder Sachdev, John Bankart, Niels Peter Ole Mors, Richard Lipton, Mindy Katz, Peter T. Fox, Mohammad Zia Katshu, M. Sriram Iyengar, Galit Weinstein, Hamid R. Sohrabi, Rachel Jenkins, Dan J. Stein, Jacques Hugon, Venetsanos Mavreas, John Blangero, Carlos Cruchaga, Murali Krishna, Ovais Wadoo, Rodrigo Becerra, Igor Zwir, William T. Longstreth, Golo Kroenenberg, Paul Edison, Elizabeta Mukaetova‐Ladinska, Ekkehart Staufenberg, Mariana Figueredo‐Aguiar, Agustín Yécora, Fabiana Vaca, Hernan P. Zamponi, Vincenzina Lo Re, Abdul Majid, Jonas Sundarakumar, Hector M. Gonzalez, Mirjam I. Geerlings, Ingmar Skoog, Alberto Salmoiraghi, Filippo Martinelli Boneschi, Vibuthi N. Patel, Juan M. Santos, Guillermo Rivera Arroyo, Antonio Caballero Moreno, Pascal Felix, Carla Gallo, Hidenori Arai, Masahito Yamada, Takeshi Iwatsubo, Malveeka Sharma, Nandini Chakraborty, Catterina Ferreccio, Dickens Akena, Carol Brayne, Gladys Maestre, Sarah Williams Blangero, Luis I. Brusco, Prabha Siddarth, Timothy M. Hughes, Alfredo Ramírez Zuñiga, Joseph Kambeitz, Agustin Ruiz Laza, Norrina Allen, Stella Panos, David Merrill, Agustín Ibáñez, Debby Tsuang, Nino Valishvili, Srishti Shrestha, Sophia Wang, Vasantha Padma, Kaarin J. Anstey, Vijayalakshmi Ravindrdanath, Kaj Blennow, Paul Mullins, Emilia Łojek, Anand Pria, Thomas H. Mosley, Penny Gowland, Timothy D. Girard, Richard Bowtell & Farhaan S. Vahidy. (2022) Chronic neuropsychiatric sequelae of SARS‐CoV‐2: Protocol and methods from the Alzheimer's Association Global Consortium. Alzheimer's & Dementia: Translational Research & Clinical Interventions 8:1.
Crossref
Massimiliano Runfola, Michele Perni, Xiaoting Yang, Maria Marchese, Andrea Bacci, Serena Mero, Filippo M. Santorelli, Beatrice Polini, Grazia Chiellini, Daniela Giuliani, Antonietta Vilella, Martina Bodria, Eleonora Daini, Eleonora Vandini, Simon Rudge, Sheraz Gul, Michale O. J. Wakelam, Michele Vendruscolo & Simona Rapposelli. (2021) Identification of a Thyroid Hormone Derivative as a Pleiotropic Agent for the Treatment of Alzheimer’s Disease. Pharmaceuticals 14:12, pages 1330.
Crossref
E. Josephine Boder & Ipsita A. Banerjee. (2021) Alzheimer’s Disease: Current Perspectives and Advances in Physiological Modeling. Bioengineering 8:12, pages 211.
Crossref
Kazuyuki Takata, Florent Ginhoux & Shun Shimohama. (2021) Roles of microglia in Alzheimer’s disease and impact of new findings on microglial heterogeneity as a target for therapeutic intervention. Biochemical Pharmacology 192, pages 114754.
Crossref
Priscila Baltazar Gonçalves, Ana Carolina Rennó Sodero & Yraima Cordeiro. (2021) Green Tea Epigallocatechin-3-gallate (EGCG) Targeting Protein Misfolding in Drug Discovery for Neurodegenerative Diseases. Biomolecules 11:5, pages 767.
Crossref
Stefania Ippati, Lars Matthias Ittner & Yazi Diana Ke. 2021. Sex and Gender Differences in Alzheimer's Disease. Sex and Gender Differences in Alzheimer's Disease 3 22 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.